AGOMELATINE

作品数:9被引量:12H指数:2
导出分析报告
相关领域:医药卫生更多>>
相关作者:高哲石刘燕更多>>
相关机构:上海市精神卫生中心更多>>
相关期刊:《Journal of Wuhan University of Technology(Materials Science)》《药学进展》《世界临床药物》《Neural Regeneration Research》更多>>
相关基金:国家自然科学基金湖北省自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Neural Regeneration Researchx
条 记 录,以下是1-1
视图:
排序:
Agomelatine:a potential novel approach for the treatment of memory disorder in neurodegenerative disease被引量:5
《Neural Regeneration Research》2023年第4期727-733,共7页Qiang Su Tian Li Guo-Wei Liu Yan-Li Zhang Jun-Hong Guo Zhao-Jun Wang Mei-Na Wu Jin-Shun Qi 
supported by Shanxi“1331 Project”Key Subjects Construction,No.1331KSC(to JSQ);Science Research Start-up Fund for Doctors of Shanxi Province,No.SD2011(to TL);Science Research Start-Up Fund for Doctors of Shanxi Medical University,No.XD2017(to TL)。
Agomelatine is a selective agonist of melatonin receptor 1A/melatonin receptor 1B(MT/MT)and antagonist of 5-hydroxytryptamine 2C receptors.It is used clinically to treat major depressive episodes in adults.The pro-chr...
关键词:AGOMELATINE ANTIDEPRESSANT ANXIETY APATHY circadian-rhythm sleep disorder cognitive impairment depression melatonergic memory disorder mood disorder neurodegenerative disease 
检索报告 对象比较 聚类工具 使用帮助 返回顶部